Exubera is a “Success,” says Pfizer’s Read
Make a commentBy Ed Silverman // January 22nd, 2007 // 1:36 pm
Never mind increasing chatter about long-term safety, price and insurance reimbursement - not to mention that the inhaled insulin product looks like a bong - Pfizer’s Ian Read went out of his way today to call Exubera an “innovation.”
For the latest look at concerns, though, take a peek at this story in The Los Angeles Times the other day. Not a pretty picture.
But Pfizer is adamant and plans a major campaign to boost disappointing sales. Whether you believe the drugmaker can succeed may depend on what you inhale.
[tags]Exubera, Pfizer[/tags]